UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 8, 2015 (December 2, 2015)
Commission File Number: 0-24260
Amedisys, Inc.
(Exact Name of Registrant as specified in its Charter)
| Delaware | 11-3131700 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
5959 S. Sherwood Forest Blvd., Baton Rouge, LA 70816
(Address of principal executive offices, including zip code)
(225) 292-2031 or (800) 467-2662
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
1
Section 2 – Financial Information
Item 2.01. Completion of Acquisition or Disposition of Assets
Effective as of December 2, 2015, Amedisys, Inc., (the “Company”), through its indirect, wholly-owned subsidiary, Amedisys Property, L.L.C., completed the previously-announced sale of its corporate headquarters building (and surrounding land) located in Baton Rouge Louisiana, which transaction included the sale of certain personal property located in and around the corporate headquarters building and related assets, for a total cash purchase price of $20.0 million (which purchase price was subject to customary adjustments for closing costs and the Company’s pro rata share of 2015 property taxes). As previously disclosed, the purchaser was Franciscan Missionaries of Our Lady of the Lake Health System, Inc.
2
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| AMEDISYS, INC. | ||
| By: | /s/ Ronald A. LaBorde | |
| Ronald A. LaBorde | ||
| Vice Chairman and Chief Financial Officer | ||
DATE: December 8, 2015
3